Kevin Hicok

Kevin Hicok has over thirty years of experience in the cell therapy and regenerative medicine fields. After 11 years at the Mayo Clinic studying autoimmune and bone-related diseases, he joined one of the pioneering adipose cell therapy companies, Artecel Therapeutics where he in collaboration with Obatala co-founder, Dr. Jeffrey Gimble and the rest of the Artecel team demonstrated the ability of adipose-derived cells to differentiate into bone, cartilage and neuro/glial progenitors. He continued his work in the adipose therapy space at Cytori Therapeutics, VetStem Biologics, and Gallant focusing on later-stage therapy development in both human and veterinary sectors.